Clinical trials sponsored by Samsung Medical Center

Phase breakdown

Conditions studied

Recruiting trials led by Samsung Medical Center

• A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry
  NCT05566249 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Anesthesia and Non-small Cell Lung Cancer Recurrence
  NCT06330038 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Brain Metastasis Development Mechanism in BCBM Patients
  NCT06330870 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: Female · 1 location
• Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
  NCT03791034 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female) · 1 location
• Clinical Impact of SGLT2 Inhibitor After DC Cardioversion in Persistent AF With HFpEF
  NCT07776054 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 2 locations
• Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors
  NCT06729684 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: Female · 1 location
• Digital Therapeutics for Social Cognitive Function in Schizophrenia Spectrum Disorder
  NCT07755605 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years to 60 Years · Sex: All (male and female) · 1 location
• Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation
  NCT07447297 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Efficacy of Early Rhythm Control in AF With TR Patients
  NCT07607093 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Empirical Anatomy-Based Ablation vs Emphasize Map-Guided Substrate Ablation in Persistent Atrial Fibrillation : (COMPASS-AF)
  NCT07726901 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · 2 locations
• Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy
  NCT03578185 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Impact of Optimized Pacing Strategies on Clinical and Hemodynamic Outcomes in Heart Failure Patients With Pacemaker
  NCT07563153 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib Treatment
  NCT06106802 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease
  NCT07753200 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer
  NCT05933733 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: Female · 1 location
• Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma
  NCT05528458 · Phase: Phase 2 · Ages: 30 Years to 75 Years · Sex: All (male and female) · 1 location
• PULSAR in Systemic Therapy for Pancreatic Cancer
  NCT07269626 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention
  NCT04899479 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients
  NCT06350617 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer
  NCT05893966 · Phase: Not specified · Ages: 19 Years and older · Sex: Female · 1 location
• Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer
  NCT05896865 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: Female · 1 location
• Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in Patients With Heart Failure With Reduced Ejection Fraction Caused by Non-ischemic Etiology
  NCT06243653 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Revascularization Versus Medical Treatment in Patients With Ischemic Left Ventricular Dysfunction
  NCT05828719 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)
  NCT06461819 · Phase: Phase 2 · Ages: 20 Years and older · Sex: Male · 1 location
• Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)
  NCT06461793 · Phase: Phase 2 · Ages: 20 Years and older · Sex: Male · 1 location
• Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer
  NCT07500701 · Phase: Phase 3 · Ages: 20 Years and older · Sex: Male · 1 location
• The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]
  NCT02688894 · Phase: Not specified · Ages: 20 Years and older · Sex: All (male and female) · 6 locations
• The Prognostic Role and Diagnostic Efficacy of Exercise Right Heart Catheterization With a Simultaneous Echocardiography in Patients With Dyspnea on Exertion
  NCT05490901 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
  NCT03637569 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Resistance Mechanism of Trastuzumab Deruxtexan in HER2 Positive Breast Cancer Patients.
  NCT06330012 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: Female · 1 location
• Thoracoscopic Versus Catheter Ablation in Persistent Atrial Fibrillation With Enlarged Left Atrium
  NCT07783984 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Samsung Medical Center recruiting for?

Samsung Medical Center is the lead sponsor of 31 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.